Next Fertility Nordic

What Next Fertility Nordic does

Next Fertility Nordic (legally BioEximi OÜ) is an Estonian fertility clinic headquartered at Veerenni 51, Tallinn, and operated as part of the NEXTCLINICS group, which runs clinics and laboratories in 8 countries. The clinic provides a comprehensive assisted reproductive technology (ART) service line covering fertility diagnostics, IUI, IVF/ICSI, frozen embryo transfer, donor gamete cycles (including a BLAST2 blastocyst guarantee package), preimplantation genetic testing, gamete cryopreservation and pregnancy monitoring, complemented by genetic, psychological, experience-based and nutrition counseling plus physiotherapy. Its core customer segments are couples experiencing infertility, single women choosing motherhood, individuals seeking fertility preservation, and women up to age 40 covered by the Estonian Health Insurance Fund (Tervisekassa).

The clinic's technology base centers on an advanced IVF lab stack: EmbryoScope time-lapse incubation with continuous imaging, the RIWitness electronic sample identification and chain-of-custody system, CHLOE AI for embryo analysis, ERA / BeReady endometrial receptivity testing, EmbryoGlue transfer medium, and PGT. The lab is ISO 15189 accredited and the clinic holds Estonian Agency of Medicines Activity License No. 6 plus four Estonian Health Board licenses. Operations are supported by professional liability insurance from PZU Kindlustus (€3,000,000 aggregate per period).

Revenue is generated transactionally from one-time ART procedures (with one IVF cycle typically priced at €1,500–3,000), donor gamete sales, fertility preservation storage, prenatal monitoring, and supporting counseling services, plus third-party reimbursement through the Tervisekassa contract for insured women up to 40. Marketing and patient acquisition run through a multilingual website (Estonian, English, Russian, Finnish), online booking, doctor referrals, and patient testimonials, while broader access is enabled through installment partnerships with LHV, ESTO and MediCredit. The clinic also operates a B2B donor gamete ordering channel serving partner clinics across the region.

Name

Next Fertility Nordic

Legal name

BioEximi OÜ

Website

https://next-fertilitynordic.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Next Fertility Nordic (BioEximi OÜ) is a Tallinn-based fertility clinic operating under the NEXTCLINICS group, delivering IVF/ICSI, IUI, donor gametes, PGT, fertility preservation, and pregnancy monitoring to Estonian and international patients, partly reimbursed via Tervisekassa.

Ownership category

akta.pro rank

Product category

Reproductive Health Services (Fertility Clinic / IVF Services)

NAICS

Family Planning Centers (62141), Family Planning Centers (621410), Blood and Organ Banks (621991)

SIC

Services-Health Services (8000), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industry

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC)

Keywords

• Fertility clinic services
• In vitro fertilization
• Assisted reproductive technology
• Fertility diagnostics
• Pregnancy monitoring

Headquarters

HQ city

Tallinn

HQ country

Estonia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. Fertility Treatment Services: The primary revenue stream consists of fertility treatments including IUI (intrauterine insemination), IVF/ICSI (in vitro fertilization), FET (frozen embryo transfer), donor gamete cycles, embryo diagnostics, and fertility preservation procedures. Pricing varies by procedure type, with one IVF cycle typically costing €1,500–3,000.
2. Pregnancy Monitoring: Prenatal care services including midwife visits, fetal ultrasound scans, and kinesio taping for pregnant women offered as follow-on services to fertility treatment patients.
3. Donor Gametes: Biobank services providing donor eggs, donor sperm, and ordering of donor gametes for patients and partner clinics.
4. Insurance-Funded Treatments: The clinic is a contracted partner of the Estonian Health Insurance Fund (Tervisekassa), which covers fertility treatment costs for insured women up to age 40, providing a third-party reimbursement revenue stream.
5. Fertility Preservation: Gamete freezing and storage services for patients who wish to preserve fertility for future use.
6. Consulting and Counseling Services: Genetic counseling, psychological counseling, experience-based counseling, nutrition counseling, and physiotherapy services complement the medical treatment pathway.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Next Fertility Nordic is a fertility treatment clinic in Tallinn, Estonia, providing comprehensive infertility diagnostics, assisted reproduction treatments (IUI, IVF/ICSI, frozen embryo transfer), IVF with donor gametes, preimplantation genetic testing (PGT), gamete cryopreservation, and pregnancy monitoring services. The clinic operates an in-house biobank for donor eggs and donor sperm, supplies gametes to partner clinics, and runs an integrated support pathway covering genetic, psychological, experience-based, nutritional, and physiotherapy counseling under ISO 15189-accredited laboratory protocols.

Product overview

Next Fertility Nordic is a next-generation fertility clinic offering a comprehensive portfolio of assisted reproductive technology (ART) services. The core treatment pathway spans fertility testing, intrauterine insemination (IUI), and in vitro fertilization (IVF/ICSI), supported by advanced embryo monitoring technology (Embryoscope with time-lapse imaging and CHLOE AI for embryo analysis) and electronic sample identification (RI Witness). Additional services include frozen embryo transfer (FET), preimplantation genetic testing (PGT/PGS), donor gamete programs (IVF with donor eggs/sperm, BLAST2 guarantee), gamete cryopreservation, and pregnancy monitoring. Support services encompass genetic counseling, psychological counseling, experience-based peer support, physiotherapy, and nutrition counseling. The clinic operates an in-house biobank for donor gametes and partners with Tervisekassa (Estonian Health Insurance Fund) for subsidized treatment coverage.

Differentiator

Problem solved

Functional benefit

Brands

• BLAST2 Garantii: Guarantee program with donor eggs

Products and services

• Fertility Testing (Viljakuse kontroll) Comprehensive fertility examination for both men and women, including gynecological consultation, ultrasound, hormone analysis (AMH, FSH, E2, P4, PRL, TSH), infectious disease screening, and semen analysis, intended for individuals and couples seeking a fertility workup.
• In Vitro Fertilization (IVF) with ICSI In vitro fertilization procedure including ovarian stimulation, egg retrieval, laboratory fertilization, embryo culture, and embryo transfer, with ICSI (intracytoplasmic sperm injection) for male factor infertility. Targeted at couples and individuals requiring assisted reproduction.
• Intrauterine Insemination (IUI) Artificial insemination placing prepared sperm directly into the uterus, often used with donor sperm for single women or couples with mild male factor infertility.
• Frozen Embryo Transfer (FET) Transfer of previously frozen and stored embryos from a prior IVF cycle into the uterus during a prepared endometrial window.
• IVF with Donor Gametes IVF treatment using donated eggs or donor sperm for patients requiring donor gametes due to ovarian failure, male factor azoospermia, or genetic concerns.
• BLAST2 Guarantee with Donor Eggs Guaranteed blastocyst transfer program using donor eggs, offering multiple attempts until successful pregnancy or a refund option.
• Embryo Diagnostics (PGT / PGS) Preimplantation genetic testing performed on embryos to screen for chromosomal abnormalities (PGS) or specific genetic diseases (PGT), improving selection and success rates especially for women over 35.
• Pregnancy Monitoring Ongoing obstetric care following fertility treatment, including midwife consultations, fetal ultrasound scans, and kinesio taping for pregnant women.
• Gamete Preservation (Cryopreservation) Freezing and storage of eggs, sperm, or embryos for future use, including elective egg freezing for social reasons or fertility preservation before medical treatments.
• Biobank (Donor Gametes)

Quantifiable outcome

• 105 clinical pregnancies achieved in 2025
• +2 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability2 records

Feature7 records

Partnerships

Four partnerships are on record, tiered core and minor.

• NEXTCLINICS GroupcoreStrategic or Co-development PartnerNext Fertility Nordic is part of the NEXTCLINICS group, whose primary area of activity is fertility treatment and related medical services. The group operates clinics and laboratories in 8 countries, enabling cross-border expertise and best practice sharing. Next Fertility Nordic leverages the group's resources and standards for integrated fertility care.
• Estonian Health Insurance Fund (Tervisekassa)coreStrategic or Co-development PartnerNext Fertility Nordic (BioEximi OÜ) is a contracted partner of the Estonian Health Insurance Fund for fertility treatment. Tervisekassa covers the costs of fertility treatment procedures, related visits, and pregnancy confirmation for insured women up to age 40 (inclusive). This enables subsidized access to fertility care for eligible patients.
• LHV, ESTO, and MediCreditminorGTM or Marketing PartnerThe clinic offers flexible installment payment options in partnership with LHV, ESTO, and MediCredit to enable patients to finance fertility treatments and access care without waiting for full upfront payment.
• PZU Kindlustus (AB Lietuvos draudimas Estonian Branch)minorStrategic or Co-development PartnerPZU Kindlustus insurance provider covering the clinic's activities. Insurance coverage period 09.11.2024–08.11.2025, with total sum of €3,000,000 per insurance period, €300,000 per insurance event, and €100,000 per entitled person. Non-material damage coverage of €100,000 per event and €30,000 per entitled person.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Carrot Fertility: US-based digital fertility benefits platform partnering with employers to direct patients to fertility clinics. Not a clinic but a payer/distribution channel that increasingly routes patients to clinics like Next Fertility Nordic; relevant for understanding cross-border fertility demand and employer-sponsored fertility benefits.

Others

• Vitrolife: Swedish-listed ART media, disposable, and time-lapse incubator provider (EmbryoScope, Geri). Not a competitor but a key technology supplier to Next Fertility Nordic; useful comp for ART lab-tech economics and adoption trends.
• CooperSurgical (Wallace/Origio): US-headquartered ART consumables and device manufacturer, supplier of RIWitness electronic witnessing used by Next Fertility Nordic. Adjacent ecosystem participant rather than a clinic peer.

Broad incumbents

• Monash IVF Group: Public fertility clinic operator across Australia and Southeast Asia offering IVF, IUI, donor programs, and genetic testing. Comparable in service breadth and use of advanced ART lab technology, though at materially larger scale.
• Genea Fertility: Australia-headquartered fertility clinic group and embryology technology developer (Geri time-lapse incubators, comparable to EmbryoScope). Comparable tech-led positioning and clinic-network model, though geographically distant.
• IVI-RMA Global (Eugin Group): World's largest fertility treatment network with clinics across Europe, the Americas, and the Middle East. Operates in adjacent geographies (Spain, Nordic neighbors) and competes for medical-tourism patients, with broader brand and capital base than Next Fertility Nordic.
• Virtus Health: Multi-country fertility clinic operator (Australia, Ireland, UK, Denmark/Singapore) with integrated diagnostics and day-surgery. Comparable integrated fertility model and cross-border patient flow, larger scale than Next Fertility Nordic.

Direct peers

• CCRM Fertility: US-based fertility clinic network known for high IVF success rates and proprietary lab protocols. Comparable on technology-led differentiation and outcome reporting, though operating in a different reimbursement and regulatory environment.
• Nova Vita Kliinik: Estonian fertility clinic (Tallinn/Pärnu) offering IVF, IUI, donor gametes, and fertility diagnostics to the same domestic patient base. Direct competitor for Tervisekassa-funded and self-pay cycles, with overlapping language coverage (Estonian, English, Russian).

Regional players

• Gyncentrum: Polish fertility clinic group offering IVF, IUI, donor gametes, and PGT with strong medical-tourism positioning for Western European and Nordic patients. Comparable on price-competitive regional fertility services targeting cross-border patient flows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks1 record

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/next-fertility-nordic

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Next Fertility Nordic